T

Transimex

BE0445.206.145

About Transimex

Transimex is a cooperative company with limited liability (CVBA/SCRL, legacy) based in Wingene, founded in 1991. According to the company register, Transimex has the status "Opening faillissement". No annual accounts of Transimex are available yet.

Juridical situation
Opening faillissement
Company number
0445.206.145
Founding date
Founded in 09-08-1991
EUID number
BEKBOBCE.0445.206.145
Type of enterprise
Rechtspersoon
Location
Hazelnotedreef 18 Wingene 8750
Juridical form
CVBA — Cooperative company with limited liability (CVBA/SCRL, legacy)

Publications 6

All publications
  • Rubriek Einde (Stopzetting, Intrekking Stopzetting, Nietigheid, Ger. Ak., Gerechtelijke Reorganisatie, Enz... 06/05/2024
  • Rubriek Einde (Stopzetting, Intrekking Stopzetting, Nietigheid, Ger. Ak., Gerechtelijke Reorganisatie, Enz... 26/10/1995
  • Rubriek Einde (Stopzetting, Intrekking Stopzetting, Nietigheid, Ger. Ak., Gerechtelijke Reorganisatie, Enz... - Ontslagen - Benoemingen 31/12/1994
  • Maatschappelijke Zetel 23/09/1992
  • Benaming 23/11/1991

Frequently asked questions

Answers to the most common questions about Transimex, based on official government data and the filed annual accounts.

What is the VAT number of Transimex?

The VAT number of Transimex is BE0445.206.145.

When was Transimex established?

Transimex was founded in 09-08-1991.

What is the official address of Transimex?

The official address of Transimex is Hazelnotedreef 18 Wingene 8750.

What is the legal form of Transimex?

The juridical form of Transimex is Cooperative company with limited liability (CVBA/SCRL, legacy).

What is the annual revenue of Transimex?

Transimex has not (yet) filed an annual report, so there are no revenue figures available.

Is Transimex a reliable company?

Transimex is a registered Rechtspersoon with company number 0445.206.145 and can be verified through the official CBE database.

Is Transimex still active?

Transimex currently has the status "Opening faillissement" and is not active.

Further reading

View all insights

Sources